| |
 |
|
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
194 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1,792 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1,045 |
| 424/277.1 |
Cancer cell or component thereof |
384 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
209 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
203 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
134 |
| 424/193.1 |
Conjugate or complex |
846 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
96 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
968 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
468 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
250 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
245 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
585 |
| 424/204.1 |
Virus or component thereof |
999 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7049098 |
Method of vaccination comprising linear and circular expression elements |
May. 23, 2006 |
| 7049302 |
Compositions of CPG and saponin adjuvants and uses thereof |
May. 23, 2006 |
| 7045122 |
Salmonella vaccine |
May. 16, 2006 |
| 7045134 |
Borellia burgdorferi epitope peptides |
May. 16, 2006 |
| 7045314 |
Method for the production of bacterial toxins |
May. 16, 2006 |
| 7045596 |
Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
May. 16, 2006 |
| 7045598 |
Recombinant infectious laryngotracheitis virus and uses thereof |
May. 16, 2006 |
| 7041792 |
Type F botulinum toxin and use thereof |
May. 9, 2006 |
| 7041294 |
Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
May. 9, 2006 |
| 7041295 |
Compounds for treatment of infectious and immune system disorders and methods for their use |
May. 9, 2006 |
| 7041296 |
Methods of treating inflammatory bowel disease using cholera toxin B subunit |
May. 9, 2006 |
| 7041441 |
Phage display of intact domains at high copy number |
May. 9, 2006 |
| 7037495 |
Antimicrobial compositions |
May. 2, 2006 |
| 7037499 |
Adjuvant for transcutaneous immunization |
May. 2, 2006 |
| 7037500 |
Method for using phagocytic particles and ATP receptors to deliver antigens to MHC class I receptors to induce immunity against microbial pathogens or tumors or to suppress immunity |
May. 2, 2006 |
| 7037503 |
Compounds and methods for the treatment and prevention of bacterial infection |
May. 2, 2006 |
| 7037510 |
Hybrids of M. tuberculosis antigens |
May. 2, 2006 |
| 7038012 |
Enrichment process for H. pylori neutrophil activating protein (NAP) utilizing metal chelate chromatography |
May. 2, 2006 |
| 7038029 |
Immunostimulatory oligonucleotides and uses thereof |
May. 2, 2006 |
| 7038035 |
Vaccine-induced hepatitis B viral strain and uses thereof |
May. 2, 2006 |
| 7033795 |
FabK variant |
Apr. 25, 2006 |
| 7033572 |
Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
Apr. 25, 2006 |
| 7033591 |
Immunostimulant bacterial membrane fractions in cancer treatment |
Apr. 25, 2006 |
| 7029678 |
Vaccines |
Apr. 18, 2006 |
| 7029683 |
Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses |
Apr. 18, 2006 |
| 7029684 |
Antigenic composition of a Pseudomonas aeruginosa |
Apr. 18, 2006 |
| 7030211 |
Antigenic peptides derived from telomerase |
Apr. 18, 2006 |
| 7030219 |
B7-DC, Dendritic cell co-stimulatory molecules |
Apr. 18, 2006 |
| 7026127 |
Reg-like protein |
Apr. 11, 2006 |
| 7026128 |
Allergenic proteins and peptides from dog dander and uses therefor |
Apr. 11, 2006 |
| 7026300 |
One step immunization procedure for inducing a Chlamydia specific immune response |
Apr. 11, 2006 |
| 7026443 |
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions |
Apr. 11, 2006 |
| 7026465 |
Fusion proteins of Mycobacterium tuberculosis |
Apr. 11, 2006 |
| 7026467 |
High resolution typing system for pathogenic Mycobaterium tuberculosum |
Apr. 11, 2006 |
| 7022325 |
CD8 epitope from HIV-1 protein Vpu |
Apr. 4, 2006 |
| 7022328 |
Therapeutic and diagnostic compositions |
Apr. 4, 2006 |
| 7022496 |
Use of gene product of adenovirus early region 4 ORF-6 to inhibit repair of double-strand breaks in DNA |
Apr. 4, 2006 |
| 7022819 |
Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof |
Apr. 4, 2006 |
| 7018616 |
Rapid serological test for paratuberculosis using fluorescence polarization technology |
Mar. 28, 2006 |
| 7018636 |
Vaccine against Gram-negative bacterial infections |
Mar. 28, 2006 |
| 7018637 |
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
Mar. 28, 2006 |
| 7018638 |
Mycoplasma hyopneumoniae bacterin vaccine |
Mar. 28, 2006 |
| 7018640 |
In ovo vaccination against coccidiosis |
Mar. 28, 2006 |
| 7014848 |
Enhanced anti-tumor immunity |
Mar. 21, 2006 |
| 7014855 |
Prevention and treatment of amyloidogenic disease |
Mar. 21, 2006 |
| 7014857 |
Anti-sepsis conjugate vaccine |
Mar. 21, 2006 |
| 7011836 |
Mutants of gram negative mucosal bacteria and application thereof in vaccines |
Mar. 14, 2006 |
| 7008624 |
Antagonists of interleukin-15 |
Mar. 7, 2006 |
| 7008625 |
Recombinant constructs of Borrelia burgdorferi |
Mar. 7, 2006 |
| 7008772 |
Compounds for immunodiagnosis of prostate cancer and methods for their use |
Mar. 7, 2006 |
|
|
|
